Prostate Cancer Clinical Trials in Tampa, FL

Prostate Cancer Clinical Trials in Tampa, FL

View the best 10 prostate cancer medical studies in Tampa, Florida. Access promising new therapies by applying to a Tampa-based Prostate Cancer clinical trial.

Top rated prostate cancer clinical trials in Tampa, Florida

Here are the top 10 medical studies for prostate cancer in Tampa, Florida

Image of H. Lee Moffitt Cancer Center and Research Institute in Tampa, United States.

PSMA PET

Recruiting1 awardPhase 2 & 3
This trial will follow patients who had high-risk results on a previous study to see if they benefit from additional testing and treatment recommendations.
Image of Ironwood Physicians P.C. dba Ironwood Cancer & Research Centers in Chandler, United States.

Talazoparib +1 More

PARP Inhibitor

Recruiting1 awardPhase 3
This trial looks at whether adding the drug talazoparib to the drug enzalutamide improves progression-free survival in men with metastatic castration-resistant prostate cancer.
Image of Arizona Urology Specialists, PLLC in Tucson, United States.

Relugolix +1 More

Hormone Therapy

Recruiting2 awardsPhase 3
This trial will compare the risk of major heart events in prostate cancer patients taking Relugolix or Leuprolide Acetate. Ages 18+. On ADT for min. 1 year.
Image of GenesisCare USA in Troy, United States.

Stereotactic Body Radiotherapy

Radiation Therapy

Recruiting1 award
This trial shows that the SpaceOAR system is effective in reducing late GI toxicity in people undergoing SBRT to treat prostate cancer.
Image of The University of California, Los Angeles in Encino, United States.

Etrumadenant

Adenosine Receptor Antagonist

Recruiting1 awardPhase 1 & 2
This trial is testing a new cancer drug, etrumadenant, to see if it is safe and effective at treating metastatic castrate resistant prostate cancer.
Image of VA Greater Los Angeles Healthcare System, West Los Angeles, CA in West Los Angeles, United States.

Pembrolizumab

Checkpoint Inhibitor

Recruiting2 awardsPhase 2
This trial is testing the efficacy of pembrolizumab, a checkpoint inhibitor, in Veterans with metastatic castration-resistant prostate cancer. The study will also compare the pre-treatment and at-progression metastatic tumor biopsies to investigate the molecular correlates of resistance and sensitivity to pembrolizumab.
Image of Local Institution in Mobile, United States.

Nivolumab +1 More

Checkpoint Inhibitor

Recruiting1 awardPhase 3
This trial is testing nivolumab with docetaxel in men with advanced prostate cancer who have not responded to other treatments.
Image of City of Hope Comprehensive Cancer Center in Duarte, United States.

Darolutamide

Recruiting1 awardPhase 3
This trial is testing if adding darolutamide to ADT (a treatment to reduce testosterone levels) is more effective than ADT alone in treating high-risk prostate cancer.
Image of Sarah Cannon Research Institute at HealthONE in Denver, United States.

AMG 340

CAR T-cell Therapy

Recruiting1 awardPhase 1
This trial is testing a new cancer treatment for men with prostate cancer that has spread and no longer responds to hormone therapy or other treatments. The goal is to find the best dose of the new treatment, which will be given alone (monotherapy). The study will first test the treatment in a small group of people to see if it is safe and what side effects it causes (dose escalation), and then in a larger group of people (dose expansion).
Image of Mobile Infirmary Medical Center in Mobile, United States.

Flutamide +3 More

Hormone Therapy

Recruiting1 awardPhase 2 & 3
This trial is testing docetaxel in combination with antiandrogen therapy and radiation therapy versus antiandrogen therapy and radiation therapy alone in treating patients with prostate cancer that has been removed by surgery.

Popular filter options for prostate-cancer tampa trials

Phase 3 Clinical Trials

View 74 phase 3 medical studies.

Clinical Trials With No Placebo

View 74 medical studies that do not have a placebo group.

Frequently Asked Questions

Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
Is there any support for travel costs?
Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.
Will I know what medication I am taking?
This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.
How long do clinical trials last?
Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.
Do you verify all the trials on your website?
All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.
How quickly will I hear back from a clinical trial?
Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.